SCHEMBL3299454

SCHEMBL3299454

[c]1ccc(-c2ccncc2)cc1-c1ccc(-c2cccnc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.47
CYP3A4 P08684 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
PIK3CA P42336 1/20 0.47
CYP11B2 P19099 7/20 0.46
CYP11B1 P15538 6/20 0.46
CYP19A1 P11511 3/20 0.46
CYP17A1 P05093 2/20 0.46
MKNK1 Q9BUB5 3/20 0.44
MKNK2 Q9HBH9 3/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2B6 P20813 1/20 0.44
CYP2C19 P33261 1/20 0.44
MEN1 O00255 1/20 0.44
PSIP1 O75475 1/20 0.44
AXL P30530 1/20 0.44
KIF11 P52732 1/20 0.42
DYRK1A Q13627 1/20 0.42
DYRK1B Q9Y463 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9958246 0.89 CYP2A6 (0.52) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B2
SCHEMBL9958676 0.85 CYP19A1 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B2
SCHEMBL28581879 0.85 NOTUM (0.56) PIK3CAMKNK1KIF11DYRK1A
SCHEMBL9958975 0.85 NOTUM (0.56) PIK3CAMKNK1KIF11DYRK1A
SCHEMBL27955545 0.85 MAPT (0.48) CYP19A1KIF11DYRK1A
SCHEMBL19817613 0.77 CYP2A6 (0.65) CYP2A6CYP3A4ALDH1A1CYP1A2PIK3CA
SCHEMBL320526 0.77 CYP2A6 (0.79) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B2
SCHEMBL29626674 0.77 CYP2A6 (0.79) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B2
SCHEMBL9958537 0.77 CYP2A6 (0.54) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B2
SCHEMBL24492814 0.76 CYP2A6 (0.62) CYP2A6CYP3A4ALDH1A1CYP1A2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741352-B2 KCNQ channel modulating compounds and their pharmaceutical use NEUROSEARCH A/S (DK) 2010-06-22 US disclosed
US-20060173058-A1 Kcnq channel modulating compounds and their pharmaceutical use NEUROSEARCH A/S (DK) 2006-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173058-A1 Kcnq channel modulating compounds and their pharmaceutical use KCNQ1, KCNQ2, KCNQ5 CYP2A6 1621/4885CYP3A4 1211/4885ALDH1A1 4394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.